25 Nov

Inspection of ambulatory surgical facilities that perform LASIK procedures is one of the options available to FDA to ensure that physicians and patients have current and accurate information to help them with their decisions about LASIK. These inspections allow FDA to identify reporting problems and provide opportunities to further educate user facilities about MDR reporting obligations. This should improve the quality of information reported to FDA and manufacturers about LASIK problems, and further enhance the quality of information made available to the public. 

Source : USFDA

* The email will not be published on the website.